Advertisement

AIDS and Behavior

, Volume 21, Issue 7, pp 1914–1925 | Cite as

Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment

  • Heidi M. CraneEmail author
  • Mary E. McCaul
  • Geetanjali Chander
  • Heidi Hutton
  • Robin M. Nance
  • Joseph A. C. Delaney
  • Joseph O. Merrill
  • Bryan Lau
  • Kenneth H. Mayer
  • Michael J. Mugavero
  • Matthew Mimiaga
  • James H. Willig
  • Greer A. Burkholder
  • Daniel R. Drozd
  • Rob J. Fredericksen
  • Karen Cropsey
  • Richard D. Moore
  • Jane M. Simoni
  • W. Christopher Mathews
  • Joseph J. Eron
  • Sonia Napravnik
  • Katerina Christopoulos
  • Elvin Geng
  • Michael S. Saag
  • Mari M. Kitahata
Original Paper

Abstract

Hazardous alcohol use is associated with detrimental health outcomes among persons living with HIV (PLWH). We examined the prevalence and factors associated with hazardous alcohol use in the current era using several hazardous drinking definitions and binge drinking defined as ≥5 drinks for men versus ≥4 for women. We included 8567 PLWH from 7 U.S. sites from 2013 to 2015. Current hazardous alcohol use was reported by 27% and 34% reported binge drinking. In adjusted analyses, current and past cocaine/crack (odd ratio [OR] 4.1:3.3–5.1, p < 0.001 and OR 1.3:1.1–1.5, p < 0.001 respectively), marijuana (OR 2.5:2.2–2.9, p < 0.001 and OR 1.4:1.2–1.6, p < 0.001), and cigarette use (OR 1.4:1.2–1.6, p < 0.001 and OR 1.3:1.2–1.5, p < 0.001) were associated with increased hazardous alcohol use. The prevalence of hazardous alcohol use remains high in the current era, particularly among younger men. Routine screening and targeted interventions for hazardous alcohol use, potentially bundled with interventions for other drugs, remain a key aspect of HIV care.

Keywords

HIV Alcohol use Hepatitis C Substance use 

Resumen

El consumo riesgoso de alcohol se asocia a los resultados adversos de salud entre las personas que viven con VIH (PLWH, por sus siglas en inglés). Estudiamos la preponderancia y los factores asociados al consumo riesgoso en la época actual con el uso de distintas definiciones de beber alcohol en forma riesgosa y consumir alcohol en forma desmedida, que se define como el consumo de ≥ 5 tragos para hombres y ≥ 4 tragos para mujeres. Incluimos a 8567 PLWH de 7 lugares distintos de EE. UU entre 2013 y 2015. El 27% informó de consumo de alcohol en forma riesgosa y el 34% informó de consumo de alcohol en forma desmedida en la actualidad. En el análisis ajustado, el consumo actual y pasado de cocaína o crack (índice de probabilidad [OR, por sus siglas en inglés] 4,1:3,3-5,1, p < 0,001 y OR 1,3:1,1-1,5, p < 0,001, respectivamente), marihuana (OR 2,5:2,2-2,9, p < 0,001 y OR 1,4:1,2-1,6, p < 0,001) y consumo de cigarrillo (OR 1,4:1,2-1,6, p < 0,001 y OR 1,3:1,2-1,5, p < 0,001) se asoció al consumo de alcohol cada vez más riesgoso. La prevalencia del consumo de alcohol en forma riesgosa permanece alta en la actualidad, en especial entre los hombres más jóvenes. Los análisis de rutina y las intervenciones dirigidas a públicos específicos para abordar el consumo riesgoso de alcohol, posiblemente en conjunto con intervenciones para abordar el consumo de otras drogas, sigue siendo un aspecto clave del tratamiento contra el VIH.

Notes

Acknowledgements

We thank the patients and providers throughout the CNICS network. This work was supported by the National Institutes of Alcohol Abuse and Alcoholism (NIAAA) at the National Institutes of Health [U24AA020801, U01AA020793 and U01AA020802]. Additional support came from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health [CNICS R24 AI067039, UW CFAR NIAID Grant P30 AI027757, UNC CFAR Grant P30 AI50410, and UAB CFAR Grant P30 AI027767].

Compliance with ethical standards

Conflicts of interest

The authors declare they have no conflicts of interest.

Informed consent

All sites have approval from Human Subjects committees at their local institution and participants signed informed consent to participate in CNICS. All data submitted to the CNICS Data Repository are deidentified. For this retrospective data analysis of existing deidentified data in the CNICS Data Repository, no additional formal consent is required.

Ethical approval

This article does not contain any studies with animals performed by any of the authors.

References

  1. 1.
    Galvan FH, Bing EG, Fleishman JA, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol. 2002;63(2):179–86.CrossRefPubMedGoogle Scholar
  2. 2.
    Chander G, Josephs J, Fleishman JA, et al. Alcohol use among HIV-infected persons in care: results of a multi-site survey. HIV Med. 2008;9(4):196–202.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Galvan FH, Burnam MA, Bing EG. Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people. J Psychoact Drugs. 2003;35(Suppl 1):153–60.CrossRefGoogle Scholar
  4. 4.
    Vagenas P, Azar MM, Copenhaver MM, Springer SA, Molina PE, Altice FL. The impact of alcohol use and related disorders on the HIV continuum of care: a systematic review: alcohol and the HIV continuum of care. Curr HIV/AIDS Rep. 2015;12(4):421–36.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Monroe AK, Lau B, Mugavero MJ, et al. Heavy alcohol use is associated with worse retention in HIV care. J Acquir Immune Defic Syndr. 2016.Google Scholar
  6. 6.
    Samet JH, Cheng DM, Libman H, Nunes DP, Alperen JK, Saitz R. Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr. 2007;46(2):194–9.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Chander G, Lau B, Moore R. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr. 2006;43(4):411–7.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Cook RL, Sereika SM, Hunt SC, Woodward WC, Erlen JA, Conigliaro J. Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med. 2001;16(2):83–8.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Braithwaite RS, Conigliaro J, Roberts MS, et al. Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care. 2007;19(4):459–66.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Stein M, Herman DS, Trisvan E, Pirraglia P, Engler P, Anderson BJ. Alcohol use and sexual risk behavior among human immunodeficiency virus-positive persons. Alcohol Clin Exp Res. 2005;29(5):837–43.CrossRefPubMedGoogle Scholar
  11. 11.
    Rehm J, Shield KD, Joharchi N, Shuper PA. Alcohol consumption and the intention to engage in unprotected sex: systematic review and meta-analysis of experimental studies. Addiction. 2012;107(1):51–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853–60.CrossRefPubMedGoogle Scholar
  13. 13.
    Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279(6):450–4.CrossRefPubMedGoogle Scholar
  14. 14.
    The Henry J Kasier Foundation. The HIV/AIDS epidemic in the United States. 2017. http://kff.org/hivaids/fact-sheet/the-hivaids-epidemic-in-the-united-states/.
  15. 15.
    Centers for Disease Control and Prevention. HIV among people aged 50 and over. 2016. https://www.cdc.gov/hiv/group/age/olderamericans/.
  16. 16.
    Cook RL, Zhu F, Belnap BH, et al. Longitudinal trends in hazardous alcohol consumption among women with human immunodeficiency virus infection, 1995-2006. Am J Epidemiol. 2009;169(8):1025–32.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Lake-Bakaar G, Grimson R. Alcohol abuse and stage of HIV disease in intravenous drug abusers. J R Soc Med. 1996;89(7):389–92.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Welch KJ. Correlates of alcohol and/or drug use among HIV-infected individuals. AIDS Patient Care STDS. 2000;14(6):317–23.CrossRefPubMedGoogle Scholar
  19. 19.
    Bertholet N, Cheng DM, Samet JH, Quinn E, Saitz R. Alcohol consumption patterns in HIV-infected adults with alcohol problems. Drug Alcohol Depend. 2010;112(1–2):160–3.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Kitahata MM, Rodriguez BG, Haubrich R, et al. Cohort profile: the Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS). Int J Epidemiol. 2008;37(5):948–55.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Fredericksen RJ, Edwards TC, Merlin JS, et al. Patient and provider priorities for self-reported domains of HIV clinical care. AIDS Care. 2015;27(10):1255–64.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Kim HN, Nance R, Van Rompaey S, et al. Poorly controlled HIV infection: an independent risk factor for liver fibrosis. J Acquir Immune Defic Syndr. 2016;72(4):437–43.CrossRefPubMedGoogle Scholar
  23. 23.
    Mimiaga MJ, Biello K, Reisner SL, et al. Latent class profiles of internalizing and externalizing psychosocial health indicators are differentially associated with sexual transmission risk: findings from the CFAR Network of Integrated Clinical Systems (CNICS) cohort study of HIV-infected men engaged in primary care in the United States. Health Psychol. 2015.Google Scholar
  24. 24.
    Mimiaga MJ, Reisner SL, Grasso C, et al. Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort. Am J Public Health. 2013;103(8):1457–67.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Bradley KA, McDonell MB, Bush K, Kivlahan DR, Diehr P, Fihn SD. The AUDIT alcohol consumption questions: reliability, validity, and responsiveness to change in older male primary care patients. Alcohol Clin Exp Res. 1998;22(8):1842–9.PubMedGoogle Scholar
  26. 26.
    Bradley KA, Bush KR, Epler AJ, et al. Two brief alcohol-screening tests From the Alcohol Use Disorders Identification Test (AUDIT): validation in a female Veterans Affairs patient population. Arch Intern Med. 2003;163(7):821–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Newcombe DA, Humeniuk RE, Ali R. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site. Drug Alcohol Rev. 2005;24(3):217–26.CrossRefPubMedGoogle Scholar
  28. 28.
    WHO Assist Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183–94.CrossRefGoogle Scholar
  29. 29.
    Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158(16):1789–95.CrossRefPubMedGoogle Scholar
  31. 31.
    Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007;31(7):1208–17.CrossRefPubMedGoogle Scholar
  32. 32.
    Gual A, Segura L, Contel M, Heather N, Colom J. AUDIT-3 and AUDIT-4: effectiveness of two short forms of the alcohol use disorders identification test. Alcohol Alcoholism. 2002;37(6):591–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Lucas N, Windsor TD, Caldwell TM, Rodgers B. Psychological distress in non-drinkers: associations with previous heavy drinking and current social relationships. Alcohol Alcoholism. 2010;45(1):95–102.CrossRefPubMedGoogle Scholar
  34. 34.
    Liang W, Chikritzhs T. The association between alcohol exposure and self-reported health status: the effect of separating former and current drinkers. PLoS ONE. 2013;8(2):e55881.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Crane HM, Nance RM, Merrill JO, et al. Not all non-drinkers with HIV are equal: demographic and clinical comparisons among current non-drinkers with and without a history of prior alcohol use disorders. AIDS Care. 2017;29(2):177–84.CrossRefPubMedGoogle Scholar
  36. 36.
    Newman JC, Des Jarlais DC, Turner CF, Gribble J, Cooley P, Paone D. The differential effects of face-to-face and computer interview modes. Am J Public Health. 2002;92(2):294–7.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Perlis TE, Des Jarlais DC, Friedman SR, Arasteh K, Turner CF. Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. Addiction. 2004;99(7):885–96.CrossRefPubMedGoogle Scholar
  38. 38.
    Kurth AE, Martin DP, Golden MR, et al. A comparison between audio computer-assisted self-interviews and clinician interviews for obtaining the sexual history. Sex Transm Dis. 2004;31(12):719–26.CrossRefPubMedGoogle Scholar
  39. 39.
    Dolezal C, Marhefka SL, Santamaria EK, Leu CS, Brackis-Cott E, Mellins CA. A comparison of audio computer-assisted self-interviews to face-to-face interviews of sexual behavior among perinatally HIV-exposed youth. Arch Sex Behav. 2012;41(2):401–10.CrossRefPubMedGoogle Scholar
  40. 40.
    Bryant KJ. Expanding research on the role of alcohol consumption and related risks in the prevention and treatment of HIV/AIDS. Subst Use Misuse. 2006;41(10–12):1465–507.CrossRefPubMedGoogle Scholar
  41. 41.
    Eigenbrodt ML, Mosley TH Jr, Hutchinson RG, Watson RL, Chambless LE, Szklo M. Alcohol consumption with age: a cross-sectional and longitudinal study of the Atherosclerosis Risk in Communities (ARIC) study, 1987-1995. Am J Epidemiol. 2001;153(11):1102–11.CrossRefPubMedGoogle Scholar
  42. 42.
    Merrick EL, Horgan CM, Hodgkin D, et al. Unhealthy drinking patterns in older adults: prevalence and associated characteristics. J Am Geriatr Soc. 2008;56(2):214–23.CrossRefPubMedGoogle Scholar
  43. 43.
    Mukamal KJ, Mittleman MA, Longstreth WT Jr, Newman AB, Fried LP, Siscovick DS. Self-reported alcohol consumption and falls in older adults: cross-sectional and longitudinal analyses of the cardiovascular health study. J Am Geriatr Soc. 2004;52(7):1174–9.CrossRefPubMedGoogle Scholar
  44. 44.
    Sorock GS, Chen LH, Gonzalgo SR, Baker SP. Alcohol-drinking history and fatal injury in older adults. Alcohol. 2006;40(3):193–9.CrossRefPubMedGoogle Scholar
  45. 45.
    Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group, Smith C. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS (London, England). 2010;24(10):1537–1548.Google Scholar
  46. 46.
    Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002;34(6):831–7.CrossRefPubMedGoogle Scholar
  47. 47.
    Cheng DM, Nunes D, Libman H, et al. Impact of hepatitis C on HIV progression in adults with alcohol problems. Alcohol Clin Exp Res. 2007;31(5):829–36.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Cooper CL, Cameron DW. Effect of alcohol use and highly active antiretroviral therapy on plasma levels of hepatitis C virus (HCV) in patients coinfected with HIV and HCV. Clin Infect Dis. 2005;41(Suppl 1):S105–9.CrossRefPubMedGoogle Scholar
  49. 49.
    Fishbein DA, Lo Y, Netski D, Thomas DL, Klein RS. Predictors of hepatitis C virus RNA levels in a prospective cohort study of drug users. J Acquir Immune Defic Syndr. 2006;41(4):471–6.CrossRefPubMedGoogle Scholar
  50. 50.
    National Institute of Diabetes and Digestive and Kidney Diseases. Chronic Hepatitis C: Current Disease Management. 2010. http://digestive.niddk.nih.gov/ddiseases/pubs/chronichepc/. Accessed 3 Jan 2010.
  51. 51.
    Weis N, Lindhardt BO, Kronborg G, et al. Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study. Clin Infect Dis. 2006;42(10):1481–7.CrossRefPubMedGoogle Scholar
  52. 52.
    Loko MA, Bani-Sadr F, Valantin MA, et al. Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort. Antivir Ther. 2012;17(7):1335–43.CrossRefPubMedGoogle Scholar
  53. 53.
    Maier MM, He H, Schafer SD, Ward TT, Zaman A. Hepatitis C treatment eligibility among HIV-hepatitis C virus coinfected patients in Oregon: a population-based sample. AIDS Care. 2014;26(9):1178–85.CrossRefPubMedGoogle Scholar
  54. 54.
    Fairley CK, Sze JK, Vodstrcil LA, Chen MY. Computer-assisted self interviewing in sexual health clinics. Sex Transm Dis. 2010;37(11):665–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Heidi M. Crane
    • 1
    Email author
  • Mary E. McCaul
    • 2
  • Geetanjali Chander
    • 3
  • Heidi Hutton
    • 2
  • Robin M. Nance
    • 1
  • Joseph A. C. Delaney
    • 4
  • Joseph O. Merrill
    • 1
  • Bryan Lau
    • 5
  • Kenneth H. Mayer
    • 6
  • Michael J. Mugavero
    • 7
  • Matthew Mimiaga
    • 8
  • James H. Willig
    • 7
  • Greer A. Burkholder
    • 7
  • Daniel R. Drozd
    • 1
  • Rob J. Fredericksen
    • 1
  • Karen Cropsey
    • 9
  • Richard D. Moore
    • 3
  • Jane M. Simoni
    • 10
  • W. Christopher Mathews
    • 11
  • Joseph J. Eron
    • 12
  • Sonia Napravnik
    • 12
  • Katerina Christopoulos
    • 13
  • Elvin Geng
    • 13
  • Michael S. Saag
    • 7
  • Mari M. Kitahata
    • 1
  1. 1.Department of MedicineUniversity of WashingtonSeattleUSA
  2. 2.Department of Psychiatry and Behavioral SciencesJohns Hopkins UniversityBaltimoreUSA
  3. 3.Department of MedicineJohns Hopkins UniversityBaltimoreUSA
  4. 4.Department of EpidemiologyUniversity of WashingtonSeattleUSA
  5. 5.Department of EpidemiologyJohns Hopkins UniversityBaltimoreUSA
  6. 6.Fenway Institute and Department of MedicineHarvard Medical SchoolBostonUSA
  7. 7.Department of MedicineUniversity of Alabama at BirminghamBirminghamUSA
  8. 8.Fenway Institute and Division of PsychiatryHarvard Medical SchoolBostonUSA
  9. 9.Department of PsychiatryUniversity of Alabama at BirminghamBirminghamUSA
  10. 10.Department of PsychologyUniversity of WashingtonSeattleUSA
  11. 11.Department of MedicineUniversity of California at San DiegoSan DiegoUSA
  12. 12.Department of MedicineUniversity of North CarolinaChapel HillUSA
  13. 13.Department of MedicineUniversity of California at San FranciscoSan FranciscoUSA

Personalised recommendations